| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2007 | US20070088030 Aerosol formulations for the inhalation of beta-agonists |
| 04/19/2007 | US20070088029 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function |
| 04/19/2007 | US20070088028 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 04/19/2007 | US20070088025 Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid cb1 receptor agonists |
| 04/19/2007 | US20070088024 Active substance combination comprising a carbinol combined to at least an NSAID |
| 04/19/2007 | US20070088023 Method of administration for 5-(2-chlorophenyl)-1,2-dihydro-7-fluoro-8-methoxy-3-methyl-oyrazolo[1,4]benzodiazepine |
| 04/19/2007 | US20070088022 Tetrahydroquinolines, synthesis thereof, and intermediates thereto |
| 04/19/2007 | US20070088021 4-haloisoquinoline derivative and drug containing the same |
| 04/19/2007 | US20070088020 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 04/19/2007 | US20070088019 Macroheterocyclic compounds as kinase inhibitors |
| 04/19/2007 | US20070088018 Cb1 antagonist compounds |
| 04/19/2007 | US20070088017 Benzothiazole derivatives for the treatment of diabetes |
| 04/19/2007 | US20070088016 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure |
| 04/19/2007 | US20070088015 Non-nucleoside reverse transcriptase inhibitors |
| 04/19/2007 | US20070088014 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
| 04/19/2007 | US20070088013 6-Methyloxaalkyl exemestane compounds such as 6-Methyloxamethyl exemestane used to inhibit growth and proliferation of cancer cells; anticarcinogenic agents; antiproliferative agents |
| 04/19/2007 | US20070088012 Method of treating or preventing type-2 diabetes |
| 04/19/2007 | US20070088011 Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| 04/19/2007 | US20070088010 Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest |
| 04/19/2007 | US20070088009 Triterpene quaternary salts as biologically active surfactants |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070088007 Method for preparing analogue of vitamin D |
| 04/19/2007 | US20070088006 Preemptive Prophylaxis of Migraine |
| 04/19/2007 | US20070088005 Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 04/19/2007 | US20070088004 MAO-B inhibitors useful for treating obesity |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/19/2007 | US20070088002 Orally available sphingosine 1-phosphate receptor agonists and antagonists |
| 04/19/2007 | US20070088001 Silinane compounds as cysteine protease inhibitors |
| 04/19/2007 | US20070088000 Beta-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 04/19/2007 | US20070087999 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 04/19/2007 | US20070087998 Imidazole compounds that modulate HSP90 activity |
| 04/19/2007 | US20070087997 Methods for producing modified microcrystalline chitosan and uses therefor |
| 04/19/2007 | US20070087995 Oral administration of beta-L-thymidine tablets, pills or capsules to those already infected with hepatits B; can be coadministered with 3TC, FTC, L-FMAU, DAPD, famciclovir, penciclovir, entecavir, adefovir, lobucavir, ganciclovir or ribavirin |
| 04/19/2007 | US20070087994 A1 adenosine receptor agonists |
| 04/19/2007 | US20070087993 Method for transdifferentiation of body tissues |
| 04/19/2007 | US20070087990 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 04/19/2007 | US20070087983 Novel ubp8rp polypeptides and their use in the treatment of psoriasis |
| 04/19/2007 | US20070087982 Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences |
| 04/19/2007 | US20070087981 Water Soluble and Palatable Complexes |
| 04/19/2007 | US20070087980 azithromycin-containing aqueous pharmaceutical composition and a method for the preparation of the same |
| 04/19/2007 | US20070087979 Sulfatides for treatment of autoimmune disorders |
| 04/19/2007 | US20070087977 Methods and compositions for treating pain |
| 04/19/2007 | US20070087976 Topiramate and pharmaceutical formulations thereof |
| 04/19/2007 | US20070087975 End-stage renal disease (ESRD); propionyl L-carnitine |
| 04/19/2007 | US20070087974 Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 04/19/2007 | US20070087969 Wound healing and treatment of fibrosis |
| 04/19/2007 | US20070087964 Novel compositions and methods for modulating the acid-sensing ion channel (asic) |
| 04/19/2007 | US20070087962 Pharmaceutical compositions comprising cyclosporins |
| 04/19/2007 | US20070087960 Treating hepatitis C virus infections; antivirals have low toxicity to the host; inhibit Flaviviridae polymerase |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | US20070087957 Methods and compositions for oral administration of proteins |
| 04/19/2007 | US20070087416 Hyaluronan synthase gene and uses thereof |
| 04/19/2007 | US20070087390 Opiate, cannabinoid, and estrogen receptors |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087372 Isolated ductal fluid sample |
| 04/19/2007 | US20070087363 Therapeutic methods, compounds and compositions |
| 04/19/2007 | US20070087066 Antifungal effects of Morinda citrifolia |
| 04/19/2007 | US20070087063 Medical composition for balancing bodily processes |
| 04/19/2007 | US20070087061 Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components |
| 04/19/2007 | US20070087055 Directly compressible extended release alprazolam formulation |
| 04/19/2007 | US20070087052 Effervescent bisphosphonate formulation |
| 04/19/2007 | US20070087051 Pharmaceutical composition |
| 04/19/2007 | US20070087050 Orally Disintegratable Simvastatin Tablets |
| 04/19/2007 | US20070087046 Use of green porphyrins to treat neovasculature in the eye |
| 04/19/2007 | US20070087043 Nicotine transdermal preparation and production method thereof |
| 04/19/2007 | US20070087041 Waterless Lotion and Lotion-Treated Substrate |
| 04/19/2007 | US20070087037 Stimulation of cpt-1 as a means to reduce weight |
| 04/19/2007 | US20070087035 Nutritional composition for wound healing |
| 04/19/2007 | US20070087028 Intraluminal devices for the prevention and treatment of vascular disease |
| 04/19/2007 | US20070087025 Reiteratively layered medical devices and method of preparing same |
| 04/19/2007 | US20070087022 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 04/19/2007 | US20070087021 Method of protecting against chronic infections |
| 04/19/2007 | US20070087009 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist |
| 04/19/2007 | US20070086999 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 04/19/2007 | US20070086992 stimulating antitumor immune responses; tissue-targeted therapy; first tumour antigen is used to treat secondary tumor; biodrug for cancer immunotherapy with cyclophosphamide |
| 04/19/2007 | US20070086984 Viruses for the Treatment of Cellular Proliferative Disorders |
| 04/19/2007 | US20070086978 Colon cleansing compositions and methods |
| 04/19/2007 | US20070086977 Method of treating dermatological conditions |
| 04/19/2007 | US20070086976 Acyclic N-halamines in antibacterial materials |
| 04/19/2007 | US20070086975 Polymeric micellar complexes and drug delivery vehicles thereof |
| 04/19/2007 | US20070086974 Cetirizine compositions |
| 04/19/2007 | US20070086973 Drug delivery systems for photodynamic therapy |
| 04/19/2007 | US20070086960 Systems and methods for enhancing the appearance of teeth |
| 04/19/2007 | US20070086957 Combination of medicaments for the treatment of respiratory diseases |
| 04/19/2007 | US20070086955 Form of administration for controlling primary headaches |
| 04/19/2007 | US20070086954 Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
| 04/19/2007 | US20070086953 Medicinal Aerosol Formulation Products With Improved Chemical Stability |
| 04/19/2007 | US20070086951 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| 04/19/2007 | US20070086949 Method of bioimaging using nanocrystals of fluorescent dyes |
| 04/19/2007 | DE10238257B4 Sorbicillacton A und Sorbicillacton-A-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel Sorbicillactone A and sorbicillactone A derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 04/19/2007 | DE10212564B4 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne 1-allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine |
| 04/19/2007 | DE102005063375A1 Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen Antimicrobial preparations containing octenidine encapsulated in liposomes |
| 04/19/2007 | DE102005049385A1 Imidazolderivate als Inhibitoren von TAFIa Imidazole derivatives as inhibitors of TAFIa |
| 04/19/2007 | DE102005048897A1 Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen Diacylindazol derivatives as inhibitors of lipases and phospholipases |
| 04/19/2007 | DE102005034974A1 Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen Salt of dimethylaminomethyl-phenyl-cyclohexane, and its crystalline forms |
| 04/19/2007 | CA2675901A1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 04/19/2007 | CA2672322A1 Method for detecting a biomarker of oxidative stress in a biological sample |
| 04/19/2007 | CA2642719A1 Treatment of peripheral arterial occlusive disease |